换一批
第一作者：
Denise G,O'Mahony
第一单位：
Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.;Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
作者：
Denise G,O'Mahony [1]
;
Susan J,Ramus [2]
;
Melissa C,Southey [3]
;
Nicola S,Meagher [4]
;
Andreas,Hadjisavvas [5]
;
Esther M,John [6]
;
Ute,Hamann [7]
;
Evgeny N,Imyanitov [8]
;
Irene L,Andrulis [9]
;
Priyanka,Sharma [10]
;
Mary B,Daly [11]
;
Christopher R,Hake [12]
;
Jeffrey N,Weitzel [13]
;
Anna,Jakubowska [14]
;
Andrew K,Godwin [15]
;
Adalgeir,Arason [16]
;
Anita,Bane [17]
;
Jacques,Simard [18]
;
Penny,Soucy [18]
;
Maria A,Caligo [19]
;
Phuong L,Mai [20]
;
Kathleen B M,Claes [21]
;
Manuel R,Teixeira [22]
;
Wendy K,Chung [23]
;
Conxi,Lazaro [24]
;
Peter J,Hulick [25]
;
Amanda E,Toland [26]
;
Inge Sokilde,Pedersen [27]
;
HEBON Investigators [28]
;
Susan L,Neuhausen [29]
;
Ana,Vega [30]
;
Miguel,de la Hoya [31]
;
Heli,Nevanlinna [32]
;
Mallika,Dhawan [33]
;
Valentina,Zampiga [34]
;
Rita,Danesi [35]
;
Liliana,Varesco [35]
;
Viviana,Gismondi [36]
;
Valerio Gaetano,Vellone [37]
;
Paul A,James [38]
;
Ramunas,Janavicius [39]
;
Liene,Nikitina-Zake [40]
;
Finn Cilius,Nielsen [41]
;
Thomas,van Overeem Hansen [42]
;
Tanja,Pejovic [43]
;
Ake,Borg [44]
;
Johanna,Rantala [45]
;
Kenneth,Offit [46]
;
Marco,Montagna [47]
;
Katherine L,Nathanson [47]
;
Susan M,Domchek [48]
;
Ana,Osorio [49]
;
María J,García [50]
;
Beth Y,Karlan [51]
;
GEMO Study Collaborators [52]
;
Anna,De Fazio [53]
;
David,Bowtell [53]
;
AOCS Group [54]
;
Lesley,McGuffog [55]
;
Goska,Leslie [55]
;
Michael T,Parsons [56]
;
Thilo,Dörk [57]
;
Lisa-Marie,Speith [58]
;
Elizabeth Santana,Dos Santos [59]
;
Alexandre André B A,da Costa [60]
;
Paolo,Radice [61]
;
Paolo,Peterlongo [62]
;
Laura,Papi [63]
;
Christoph,Engel [62]
;
Eric,Hahnen [64]
;
Rita K,Schmutzler [65]
;
Barbara,Wappenschmidt [66]
;
Douglas F,Easton [66]
;
Marc,Tischkowitz [67]
;
Christian F,Singer [68]
;
Yen Yen,Tan [69]
;
Alice S,Whittemore [70]
;
Weiva,Sieh [70]
;
James D,Brenton [70]
;
Drakoulis,Yannoukakos [71]
;
Florentia,Fostira [72]
;
Irene,Konstantopoulou [73]
;
Jana,Soukupova [64]
;
Michal,Vocka [53]
;
CZECANCA Consortium [74]
;
Georgia,Chenevix-Trench [54]
;
Paul D P,Pharoah [75]
;
Antonis C,Antoniou ;
David E,Goldgar ;
Amanda B,Spurdle ;
Kyriaki,Michailidou ;
Consortium of Investigators of Modifiers of BRCA1/2 ;
Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium
作者单位：
Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.;Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
[1]
School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.
[2]
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.;Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.;Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.
[3]
School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.;The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
[4]
Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
[5]
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.;Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA.
[6]
Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
[7]
N.N. Petrov Institute of Oncology, St. Petersburg, 197758, Russia.
[8]
Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1×5, Canada.;Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
[9]
Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, 66205, USA.
[10]
Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
[11]
Waukesha Memorial Hospital-Pro Health Care, Waukesha, WI, 53188, USA.
[12]
The University of Kansas Cancer Center, Kansas City, MO, 66160, USA.
[13]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, 171-252, Poland.;Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, 171-252, Poland.
[14]
Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
[15]
Department of Pathology, Landspitali University Hospital, Reykjavik, 101, Iceland.;BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
[16]
Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, L8V 1C3, Canada.
[17]
Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, G1V 4G2, Canada.
[18]
SOD Genetica Molecolare, University Hospital, Pisa, 56126, Italy.
[19]
Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
[20]
Centre for Medical Genetics, Ghent University, Gent, 9000, Belgium.
[21]
Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Comprehensive Cancer Center, Porto, 4200-072, Portugal.;School of Medicine and Biomedical Sciences Institute (ICBAS), University of Porto, Porto, 4050-013, Portugal.
[22]
Departments of Pediatrics and Medicine, Columbia University, New York, NY, 10032, USA.
[23]
Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, 08908, Spain.
[24]
Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, 60201, USA.;The University of Chicago Pritzker School of Medicine, Chicago, IL, 60637, USA.
[25]
Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.
[26]
Molecular Diagnostics, Aalborg University Hospital, Aalborg, 9000, Denmark.;Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, 9000, Denmark.;Department of Clinical Medicine, Aalborg University, Aalborg, 9000, Denmark.
[27]
Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
[28]
Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.;Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, 15706, Spain.;Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, 15706, Spain.
[29]
Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain.
[30]
Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, 00290, Finland.
[31]
Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, 94143-1714, USA.
[32]
Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
[33]
Romagna Cancer Registry, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, 47014, Italy.
[34]
Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, 16132, Italy.
[35]
Unit of Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, 16132, Italy.
[36]
Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, 14049-900, Brazil.
[37]
Faculty of Medicine, Institute of Biomedical Sciences, Department of Human and Medical Genetics, Vilnius University, Vilnius, LT-03101, Lithuania.;State Research Institute Centre for Innovative Medicine, Vilnius, 8410, Lithuania.
[38]
Latvian Biomedical Research and Study Centre, Riga, LV-1067, Latvia.
[39]
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark.
[40]
Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark.;Department of Clinical Medicine, Faculty of Health and Medical Sciences, , University of Copenhagen, Copenhagen, 2200, Denmark.
[41]
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, 97239, USA.;Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
[42]
Department of Oncology, Lund University and Skåne University Hospital, Lund, 222 41, Sweden.
[43]
Clinical Genetics, Karolinska Institutet, Stockholm, 171 76, Sweden.
[44]
Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.;Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
[45]
Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, 35128, Italy.
[46]
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19066, USA.
[47]
Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, 28029, Spain.;Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, 28029, Spain.;Genetics Service, Fundación Jiménez Díaz, Madrid, 28040, Spain.
[48]
Computational Oncology Group, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, 28029, Spain.
[49]
David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
[50]
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, 2145, Australia.;The University of Sydney, Sydney, NSW, 2145, Australia.
[51]
Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, 3000, Australia.
[52]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
[53]
Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
[54]
Gynaecology Research Unit, Hannover Medical School, Hannover, 30625, Germany.
[55]
Service de Génétique, Institut Curie, Paris, 75005, France.;Oncology Center, Hospital Sirio-Libanes, São Paulo, 01308-050, Brazil.;Department of Clinical Oncology, A.C.Camargo Cancer Center, São Paulo, 1509900, Brazil.
[56]
Department of Clinical Oncology, A.C.Camargo Cancer Center, São Paulo, 1509900, Brazil.;Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, 2215, USA.
[57]
Unit of Preventive Medicine: Molecular Bases of Genetic Risk, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, 20133, Italy.
[58]
Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, 20139, Italy.
[59]
Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, 27571, Italy.
[60]
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, 04107, Germany.;LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, 04103, Germany.
[61]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.
[62]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.;Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50931, Germany.
[63]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
[64]
Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, H4A 3J1, Canada.;Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 0QQ, UK.
[65]
Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
[66]
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.;Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA.
[67]
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.;Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
[68]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
[69]
Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, 15310, Greece.
[70]
Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, 12000, Czech Republic.
[71]
Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, 12000, Czech Republic.
[72]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
[73]
Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
[74]
Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus. kyriakimi@cing.ac.cy.;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. kyriakimi@cing.ac.cy.
[75]
医学主题词
人类(Humans);女(雌)性(Female);毒力(Virulence);BRCA1蛋白质(BRCA1 Protein);BRCA2蛋白质(BRCA2 Protein);卵巢肿瘤(Ovarian Neoplasms);疾病遗传易感性(Genetic Predisposition to Disease);乳腺肿瘤(Breast Neoplasms)
DOI
10.1038/s41416-023-02263-5
PMID
37076566
发布时间
2025-05-30
- 浏览0
British journal of cancer
British journal of cancer
2283-2294页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
